Patents Assigned to Ronald J. Billing
  • Monoclonal antibody specific for activated lymphocytes and monocytes
    Patent number: 5643740
    Abstract: Hybrid cell line producing monoclonal antibodies reactive with human activated lymphocytes, monocytes and cancer cells directed against a growth factor of approximately 15,000 daltons. Diagnostic and therapeutic uses of the antibody and antigen in cancer, autoimmune disease and transplant rejection are discussed.
    Type: Grant
    Filed: September 8, 1992
    Date of Patent: July 1, 1997
    Assignee: Ronald J. Billing
    Inventors: Ronald J. Billing, Paul I. Terasaki